Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 18 September 2026.
Announcements
2,178
Total raised
£9.5B
disclosed amounts
This month
£15.4M
raised so far
The expense platform secured the capital from a Seedrs campaign and the Future Fund.
"We are excited to announce this latest funding round and overwhelmed with the drive and support behind the Seedr campaign. We go into 2021 with a strong proposition as we continue using the power of Open Banking technology to drive our product innovation."
The seed round was led by Hoxton Ventures with backing from dRx Capital and Founders Factory.
"Our sole focus at Peptone is to embrace experimental failure and, in fact, acknowledge it as an absolutely vital stage in the process of getting the design of protein-based medicines right. Great science is always born out of failure. The reality is that drug discovery in Big Pharma sees only a small fraction of protein based drugs pass the preclinical stages due to their complexity. Pharma, just like any industry, is subject to the ‘power law’. A small number of innovative drugs generate disproportional benefits to patients and outsized capital returns. We are working on shifting this failure-to-success ratio in a meticulously predictable and repeatable way using the best computational methods and scalable data science. Only last week one of our clients produced a monoclonal antibody for which our platform suggested seven radical mutations. The said therapeutic protein got vastly improved. The probability of a human researcher being able to engineer this type of change is equal to 1/1,280,000,000. In layman terms you are four times more likely to win the Powerball lottery than to spontaneously find the solution our platform has identified in less than ten days. The business of protein therapeutics is a huge industry and as we grow and further develop our supercomputing capacity we can help make significant progress in the time to market for much sought-after protein-based treatments."
The London-based property platform secured the capital to fund team expansion, technology development, and a secondary market launch.
"This is a great start to 2021 and a clear demonstration of the belief investors have in the future of this business and in the property sector in general, despite the uncertainty that was caused by the pandemic and Brexit."
The financing round was led by Eos Advisory with participation from Newable Ventures and Scottish Enterprise.
"We are revolutionising oil test ing and analysis services by making conventional laboratory procedures mobile, rapid and routine"
The investment round was led by Grosvenor Group and will support new hires and international growth.
"NearSt’s funding comes at a time of seismic shifts in how we shop and what it means to be a retailer."
